ID   NQO1_HUMAN              Reviewed;         274 AA.
AC   P15559; B2R5Y9; B4DNM7; B7ZAD1; Q86UK1;
DT   01-APR-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1990, sequence version 1.
DT   10-MAY-2017, entry version 188.
DE   RecName: Full=NAD(P)H dehydrogenase [quinone] 1;
DE            EC=1.6.5.2;
DE   AltName: Full=Azoreductase;
DE   AltName: Full=DT-diaphorase;
DE            Short=DTD;
DE   AltName: Full=Menadione reductase;
DE   AltName: Full=NAD(P)H:quinone oxidoreductase 1;
DE   AltName: Full=Phylloquinone reductase;
DE   AltName: Full=Quinone reductase 1;
DE            Short=QR1;
GN   Name=NQO1; Synonyms=DIA4, NMOR1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Liver;
RX   PubMed=2843525;
RA   Jaiswal A.K., McBride O.W., Adesnik M., Nebert D.W.;
RT   "Human dioxin-inducible cytosolic NAD(P)H:menadione oxidoreductase.
RT   cDNA sequence and localization of gene to chromosome 16.";
RL   J. Biol. Chem. 263:13572-13578(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=1657151; DOI=10.1021/bi00108a007;
RA   Jaiswal A.K.;
RT   "Human NAD(P)H:quinone oxidoreductase (NQO1) gene structure and
RT   induction by dioxin.";
RL   Biochemistry 30:10647-10653(1991).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT SER-187.
RG   NIEHS SNPs program;
RL   Submitted (APR-2003) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 2 AND 3), AND
RP   VARIANT SER-187.
RC   TISSUE=Amygdala;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15616553; DOI=10.1038/nature03187;
RA   Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X.,
RA   Xie G., Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A.,
RA   Bajorek E., Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J.,
RA   Buckingham J.M., Callen D.F., Campbell C.S., Campbell M.L.,
RA   Campbell E.W., Caoile C., Challacombe J.F., Chasteen L.A.,
RA   Chertkov O., Chi H.C., Christensen M., Clark L.M., Cohn J.D.,
RA   Denys M., Detter J.C., Dickson M., Dimitrijevic-Bussod M., Escobar J.,
RA   Fawcett J.J., Flowers D., Fotopulos D., Glavina T., Gomez M.,
RA   Gonzales E., Goodstein D., Goodwin L.A., Grady D.L., Grigoriev I.,
RA   Groza M., Hammon N., Hawkins T., Haydu L., Hildebrand C.E., Huang W.,
RA   Israni S., Jett J., Jewett P.B., Kadner K., Kimball H., Kobayashi A.,
RA   Krawczyk M.-C., Leyba T., Longmire J.L., Lopez F., Lou Y., Lowry S.,
RA   Ludeman T., Manohar C.F., Mark G.A., McMurray K.L., Meincke L.J.,
RA   Morgan J., Moyzis R.K., Mundt M.O., Munk A.C., Nandkeshwar R.D.,
RA   Pitluck S., Pollard M., Predki P., Parson-Quintana B., Ramirez L.,
RA   Rash S., Retterer J., Ricke D.O., Robinson D.L., Rodriguez A.,
RA   Salamov A., Saunders E.H., Scott D., Shough T., Stallings R.L.,
RA   Stalvey M., Sutherland R.D., Tapia R., Tesmer J.G., Thayer N.,
RA   Thompson L.S., Tice H., Torney D.C., Tran-Gyamfi M., Tsai M.,
RA   Ulanovsky L.E., Ustaszewska A., Vo N., White P.S., Williams A.L.,
RA   Wills P.L., Wu J.-R., Wu K., Yang J., DeJong P., Bruce D.,
RA   Doggett N.A., Deaven L., Schmutz J., Grimwood J., Richardson P.,
RA   Rokhsar D.S., Eichler E.E., Gilna P., Lucas S.M., Myers R.M.,
RA   Rubin E.M., Pennacchio L.A.;
RT   "The sequence and analysis of duplication-rich human chromosome 16.";
RL   Nature 432:988-994(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Colon;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-82, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 4-274 IN COMPLEX WITH FAD,
RP   AND SUBUNIT.
RX   PubMed=10543876; DOI=10.1021/jm991060m;
RA   Skelly J.V., Sanderson M.R., Suter D.A., Baumann U., Read M.A.,
RA   Gregory D.S.J., Bennett M., Hobbs S.M., Neidle S.;
RT   "Crystal structure of human DT-diaphorase: a model for interaction
RT   with the cytotoxic prodrug 5-(aziridin-1-yl)-2,4-dinitrobenzamide
RT   (CB1954).";
RL   J. Med. Chem. 42:4325-4330(1999).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) IN COMPLEX WITH FAD AND
RP   DUROQUINONE.
RX   PubMed=10706635; DOI=10.1073/pnas.97.7.3177;
RA   Faig M., Bianchet M.A., Talalay P., Chen S., Winski S., Ross D.,
RA   Amzel L.M.;
RT   "Structures of recombinant human and mouse NAD(P)H:quinone
RT   oxidoreductases: species comparison and structural changes with
RT   substrate binding and release.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:3177-3182(2000).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) IN COMPLEX WITH FAD AND THE
RP   INHIBITOR ES936, AND MASS SPECTROMETRY.
RX   PubMed=11735396; DOI=10.1021/bi011324i;
RA   Winski S.L., Faig M., Bianchet M.A., Siegel D., Swann E., Fung K.,
RA   Duncan M.W., Moody C.J., Amzel L.M., Ross D.;
RT   "Characterization of a mechanism-based inhibitor of NAD(P)H:quinone
RT   oxidoreductase 1 by biochemical, X-ray crystallographic, and mass
RT   spectrometric approaches.";
RL   Biochemistry 40:15135-15142(2001).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) IN COMPLEXES WITH FAD AND
RP   INHIBITORS, AND SUBUNIT.
RX   PubMed=11587640; DOI=10.1016/S0969-2126(01)00636-0;
RA   Faig M., Bianchet M.A., Winski S., Hargreaves R., Moody C.J.,
RA   Hudnott A.R., Ross D., Amzel L.M.;
RT   "Structure-based development of anticancer drugs: complexes of
RT   NAD(P)H:quinone oxidoreductase 1 with chemotherapeutic quinones.";
RL   Structure 9:659-667(2001).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (2.75 ANGSTROMS) IN COMPLEX WITH THE INHIBITOR
RP   DICOUMAROL.
RX   PubMed=16700548; DOI=10.1021/bi0600087;
RA   Asher G., Dym O., Tsvetkov P., Adler J., Shaul Y.;
RT   "The crystal structure of NAD(P)H quinone oxidoreductase 1 in complex
RT   with its potent inhibitor dicoumarol.";
RL   Biochemistry 45:6372-6378(2006).
RN   [15]
RP   VARIANT SER-187.
RX   PubMed=1737339;
RA   Traver R.D., Horikoshi T., Danenberg K.D., Stadlbauer T.H.,
RA   Danenberg P.V., Ross D., Gibson N.W.;
RT   "NAD(P)H:quinone oxidoreductase gene expression in human colon
RT   carcinoma cells: characterization of a mutation which modulates DT-
RT   diaphorase activity and mitomycin sensitivity.";
RL   Cancer Res. 52:797-802(1992).
RN   [16]
RP   VARIANT SER-187.
RX   PubMed=10447260;
RX   DOI=10.1002/(SICI)1098-1004(1999)14:1<67::AID-HUMU8>3.0.CO;2-5;
RA   Kristiansen O.P., Larsen Z.M., Johannesen J., Nerup J.,
RA   Mandrup-Poulsen T., Pociot F.;
RT   "No linkage of P187S polymorphism in NAD(P)H: quinone oxidoreductase
RT   (NQO1/DIA4) and type 1 diabetes in the Danish population.";
RL   Hum. Mutat. 14:67-70(1999).
CC   -!- FUNCTION: The enzyme apparently serves as a quinone reductase in
CC       connection with conjugation reactions of hydroquinons involved in
CC       detoxification pathways as well as in biosynthetic processes such
CC       as the vitamin K-dependent gamma-carboxylation of glutamate
CC       residues in prothrombin synthesis.
CC   -!- CATALYTIC ACTIVITY: NAD(P)H + a quinone = NAD(P)(+) + a
CC       hydroquinone.
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC   -!- ENZYME REGULATION: Inhibited by dicoumarol.
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:10543876,
CC       ECO:0000269|PubMed:10706635, ECO:0000269|PubMed:11587640,
CC       ECO:0000269|PubMed:11735396, ECO:0000269|PubMed:16700548}.
CC   -!- INTERACTION:
CC       Self; NbExp=5; IntAct=EBI-3989435, EBI-3989435;
CC       Q9UK53:ING1; NbExp=3; IntAct=EBI-3989435, EBI-399198;
CC       O88898-2:Tp63 (xeno); NbExp=2; IntAct=EBI-3989435, EBI-2338228;
CC       O88898-6:Tp63 (xeno); NbExp=2; IntAct=EBI-3989435, EBI-2338244;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=P15559-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P15559-2; Sequence=VSP_042716;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=P15559-3; Sequence=VSP_044446;
CC         Note=No experimental confirmation available.;
CC   -!- INDUCTION: By dioxin.
CC   -!- MASS SPECTROMETRY: Mass=30864; Mass_error=6; Method=Electrospray;
CC       Range=2-274; Evidence={ECO:0000269|PubMed:11735396};
CC   -!- POLYMORPHISM: The Ser-187 polymorphism may be linked to
CC       susceptibility to forms of cancers.
CC   -!- MISCELLANEOUS: Quinone reductase accepts electrons from both NADH
CC       and NADPH with equal efficiency.
CC   -!- SIMILARITY: Belongs to the NAD(P)H dehydrogenase (quinone) family.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/NQO1ID375.html";
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/nqo1/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; J03934; AAA59940.1; -; mRNA.
DR   EMBL; M81600; AAB60701.1; -; Genomic_DNA.
DR   EMBL; M81596; AAB60701.1; JOINED; Genomic_DNA.
DR   EMBL; M81597; AAB60701.1; JOINED; Genomic_DNA.
DR   EMBL; M81598; AAB60701.1; JOINED; Genomic_DNA.
DR   EMBL; M81599; AAB60701.1; JOINED; Genomic_DNA.
DR   EMBL; AY281093; AAP20940.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AK297979; BAG60289.1; -; mRNA.
DR   EMBL; AK312368; BAG35286.1; -; mRNA.
DR   EMBL; AK316246; BAH14617.1; -; mRNA.
DR   EMBL; AC092115; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471092; EAW83283.1; -; Genomic_DNA.
DR   EMBL; CH471092; EAW83284.1; -; Genomic_DNA.
DR   EMBL; BC007659; AAH07659.1; -; mRNA.
DR   CCDS; CCDS10883.1; -. [P15559-1]
DR   CCDS; CCDS32471.1; -. [P15559-3]
DR   CCDS; CCDS32472.1; -. [P15559-2]
DR   PIR; A41135; A30879.
DR   RefSeq; NP_000894.1; NM_000903.2. [P15559-1]
DR   RefSeq; NP_001020604.1; NM_001025433.1. [P15559-2]
DR   RefSeq; NP_001020605.1; NM_001025434.1. [P15559-3]
DR   UniGene; Hs.406515; -.
DR   PDB; 1D4A; X-ray; 1.70 A; A/B/C/D=2-274.
DR   PDB; 1DXO; X-ray; 2.50 A; A/B/C/D=2-274.
DR   PDB; 1GG5; X-ray; 2.50 A; A/B/C/D=2-274.
DR   PDB; 1H66; X-ray; 2.00 A; A/B/C/D=3-274.
DR   PDB; 1H69; X-ray; 1.86 A; A/B/C/D=3-274.
DR   PDB; 1KBO; X-ray; 2.30 A; A/B/C/D=2-274.
DR   PDB; 1KBQ; X-ray; 1.80 A; A/B/C/D=2-274.
DR   PDB; 1QBG; X-ray; 2.30 A; A/B/C/D=4-274.
DR   PDB; 2F1O; X-ray; 2.75 A; A/B/C/D/E/F/G/H=2-274.
DR   PDB; 3JSX; X-ray; 2.45 A; A/B/C/D/E/F/G/H=2-274.
DR   PDB; 4CET; X-ray; 2.20 A; A=1-274.
DR   PDB; 4CF6; X-ray; 2.69 A; A/B=1-274.
DR   PDB; 5A4K; X-ray; 2.09 A; A/B/C/D=1-274.
DR   PDB; 5EA2; X-ray; 2.01 A; A/C/E/G=1-273.
DR   PDB; 5EAI; X-ray; 2.90 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N=1-274.
DR   PDB; 5FUQ; X-ray; 2.04 A; A/B=1-274.
DR   PDBsum; 1D4A; -.
DR   PDBsum; 1DXO; -.
DR   PDBsum; 1GG5; -.
DR   PDBsum; 1H66; -.
DR   PDBsum; 1H69; -.
DR   PDBsum; 1KBO; -.
DR   PDBsum; 1KBQ; -.
DR   PDBsum; 1QBG; -.
DR   PDBsum; 2F1O; -.
DR   PDBsum; 3JSX; -.
DR   PDBsum; 4CET; -.
DR   PDBsum; 4CF6; -.
DR   PDBsum; 5A4K; -.
DR   PDBsum; 5EA2; -.
DR   PDBsum; 5EAI; -.
DR   PDBsum; 5FUQ; -.
DR   ProteinModelPortal; P15559; -.
DR   SMR; P15559; -.
DR   BioGrid; 108072; 24.
DR   DIP; DIP-24210N; -.
DR   IntAct; P15559; 5.
DR   MINT; MINT-231407; -.
DR   STRING; 9606.ENSP00000319788; -.
DR   BindingDB; P15559; -.
DR   ChEMBL; CHEMBL3623; -.
DR   DrugBank; DB00958; Carboplatin.
DR   DrugBank; DB02633; Cibacron Blue.
DR   DrugBank; DB00515; Cisplatin.
DR   DrugBank; DB00266; Dicoumarol.
DR   DrugBank; DB00997; Doxorubicin.
DR   DrugBank; DB01927; Duroquinone.
DR   DrugBank; DB03147; Flavin adenine dinucleotide.
DR   DrugBank; DB00170; Menadione.
DR   DrugBank; DB00526; Oxaliplatin.
DR   DrugBank; DB00163; Vitamin E.
DR   iPTMnet; P15559; -.
DR   PhosphoSitePlus; P15559; -.
DR   SwissPalm; P15559; -.
DR   BioMuta; NQO1; -.
DR   DMDM; 118607; -.
DR   EPD; P15559; -.
DR   MaxQB; P15559; -.
DR   PaxDb; P15559; -.
DR   PeptideAtlas; P15559; -.
DR   PRIDE; P15559; -.
DR   TopDownProteomics; P15559-1; -. [P15559-1]
DR   DNASU; 1728; -.
DR   Ensembl; ENST00000320623; ENSP00000319788; ENSG00000181019. [P15559-1]
DR   Ensembl; ENST00000379046; ENSP00000368334; ENSG00000181019. [P15559-3]
DR   Ensembl; ENST00000379047; ENSP00000368335; ENSG00000181019. [P15559-2]
DR   GeneID; 1728; -.
DR   KEGG; hsa:1728; -.
DR   UCSC; uc002exp.5; human. [P15559-1]
DR   CTD; 1728; -.
DR   DisGeNET; 1728; -.
DR   GeneCards; NQO1; -.
DR   HGNC; HGNC:2874; NQO1.
DR   HPA; CAB012421; -.
DR   HPA; HPA007308; -.
DR   MIM; 125860; gene.
DR   neXtProt; NX_P15559; -.
DR   OpenTargets; ENSG00000181019; -.
DR   PharmGKB; PA31744; -.
DR   eggNOG; ENOG410IKWF; Eukaryota.
DR   eggNOG; COG2249; LUCA.
DR   GeneTree; ENSGT00440000033410; -.
DR   HOGENOM; HOG000149970; -.
DR   HOVERGEN; HBG029104; -.
DR   InParanoid; P15559; -.
DR   KO; K00355; -.
DR   OMA; YDKGPFQ; -.
DR   OrthoDB; EOG091G183R; -.
DR   PhylomeDB; P15559; -.
DR   TreeFam; TF300296; -.
DR   BRENDA; 1.6.5.2; 2681.
DR   Reactome; R-HSA-350562; Regulation of ornithine decarboxylase (ODC).
DR   SIGNOR; P15559; -.
DR   ChiTaRS; NQO1; human.
DR   EvolutionaryTrace; P15559; -.
DR   GeneWiki; NAD(P)H_dehydrogenase_(quinone_1); -.
DR   GenomeRNAi; 1728; -.
DR   PRO; PR:P15559; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   Bgee; ENSG00000181019; -.
DR   CleanEx; HS_NQO1; -.
DR   ExpressionAtlas; P15559; baseline and differential.
DR   Genevisible; P15559; HS.
DR   GO; GO:0005737; C:cytoplasm; TAS:ProtInc.
DR   GO; GO:0005829; C:cytosol; IDA:CAFA.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0043025; C:neuronal cell body; IEA:Ensembl.
DR   GO; GO:0004128; F:cytochrome-b5 reductase activity, acting on NAD(P)H; TAS:ProtInc.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0003955; F:NAD(P)H dehydrogenase (quinone) activity; TAS:ProtInc.
DR   GO; GO:0003723; F:RNA binding; IDA:UniProtKB.
DR   GO; GO:0004784; F:superoxide dismutase activity; IEA:Ensembl.
DR   GO; GO:0007568; P:aging; IEA:Ensembl.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl.
DR   GO; GO:0043086; P:negative regulation of catalytic activity; IEA:Ensembl.
DR   GO; GO:0006809; P:nitric oxide biosynthetic process; TAS:ProtInc.
DR   GO; GO:0043525; P:positive regulation of neuron apoptotic process; IEA:Ensembl.
DR   GO; GO:0006521; P:regulation of cellular amino acid metabolic process; TAS:Reactome.
DR   GO; GO:0032355; P:response to estradiol; IEA:Ensembl.
DR   GO; GO:0045471; P:response to ethanol; IEA:Ensembl.
DR   GO; GO:0007584; P:response to nutrient; IEA:Ensembl.
DR   GO; GO:0009636; P:response to toxic substance; TAS:ProtInc.
DR   GO; GO:0007271; P:synaptic transmission, cholinergic; TAS:ProtInc.
DR   GO; GO:0006805; P:xenobiotic metabolic process; TAS:ProtInc.
DR   Gene3D; 3.40.50.360; -; 1.
DR   InterPro; IPR003680; Flavodoxin_fold.
DR   InterPro; IPR029039; Flavoprotein-like_dom.
DR   Pfam; PF02525; Flavodoxin_2; 1.
DR   SUPFAM; SSF52218; SSF52218; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome; Cytoplasm; FAD;
KW   Flavoprotein; NAD; NADP; Oxidoreductase; Phosphoprotein; Polymorphism;
KW   Reference proteome.
FT   INIT_MET      1      1       Removed. {ECO:0000250|UniProtKB:Q64669}.
FT   CHAIN         2    274       NAD(P)H dehydrogenase [quinone] 1.
FT                                /FTId=PRO_0000071622.
FT   NP_BIND      18     19       FAD. {ECO:0000269|PubMed:10543876,
FT                                ECO:0000269|PubMed:10706635,
FT                                ECO:0000269|PubMed:11735396}.
FT   NP_BIND     104    107       FAD. {ECO:0000269|PubMed:10543876,
FT                                ECO:0000269|PubMed:10706635,
FT                                ECO:0000269|PubMed:11735396}.
FT   NP_BIND     148    151       FAD. {ECO:0000269|PubMed:10543876,
FT                                ECO:0000269|PubMed:10706635,
FT                                ECO:0000269|PubMed:11735396}.
FT   REGION      126    128       Substrate binding.
FT   BINDING      12     12       FAD. {ECO:0000269|PubMed:10543876,
FT                                ECO:0000269|PubMed:10706635,
FT                                ECO:0000269|PubMed:11735396}.
FT   BINDING      67     67       FAD. {ECO:0000269|PubMed:10543876,
FT                                ECO:0000269|PubMed:10706635,
FT                                ECO:0000269|PubMed:11735396}.
FT   BINDING     156    156       FAD. {ECO:0000269|PubMed:10543876,
FT                                ECO:0000269|PubMed:10706635,
FT                                ECO:0000269|PubMed:11735396}.
FT   BINDING     201    201       FAD. {ECO:0000269|PubMed:10543876,
FT                                ECO:0000269|PubMed:10706635,
FT                                ECO:0000269|PubMed:11735396}.
FT   MOD_RES      82     82       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ     102    139       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_044446.
FT   VAR_SEQ     140    173       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_042716.
FT   VARIANT     139    139       R -> W (in dbSNP:rs1131341).
FT                                /FTId=VAR_016170.
FT   VARIANT     187    187       P -> S (lack of activity;
FT                                dbSNP:rs1800566).
FT                                {ECO:0000269|PubMed:10447260,
FT                                ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:1737339,
FT                                ECO:0000269|Ref.3}.
FT                                /FTId=VAR_008384.
FT   VARIANT     269    269       Q -> H (in dbSNP:rs34447156).
FT                                /FTId=VAR_050220.
FT   CONFLICT    252    252       F -> S (in Ref. 4; BAG60289).
FT                                {ECO:0000305}.
FT   STRAND        5     10       {ECO:0000244|PDB:1D4A}.
FT   STRAND       15     17       {ECO:0000244|PDB:1QBG}.
FT   HELIX        18     32       {ECO:0000244|PDB:1D4A}.
FT   STRAND       36     41       {ECO:0000244|PDB:1D4A}.
FT   TURN         42     46       {ECO:0000244|PDB:1D4A}.
FT   HELIX        53     55       {ECO:0000244|PDB:1D4A}.
FT   STRAND       56     58       {ECO:0000244|PDB:5EA2}.
FT   HELIX        63     65       {ECO:0000244|PDB:5EA2}.
FT   HELIX        68     78       {ECO:0000244|PDB:1D4A}.
FT   HELIX        83     94       {ECO:0000244|PDB:1D4A}.
FT   STRAND       96    103       {ECO:0000244|PDB:1D4A}.
FT   STRAND      106    108       {ECO:0000244|PDB:4CET}.
FT   HELIX       111    120       {ECO:0000244|PDB:1D4A}.
FT   TURN        124    126       {ECO:0000244|PDB:1D4A}.
FT   HELIX       129    131       {ECO:0000244|PDB:1H69}.
FT   HELIX       133    135       {ECO:0000244|PDB:1D4A}.
FT   TURN        137    140       {ECO:0000244|PDB:1D4A}.
FT   STRAND      142    148       {ECO:0000244|PDB:1D4A}.
FT   HELIX       154    156       {ECO:0000244|PDB:1D4A}.
FT   STRAND      160    162       {ECO:0000244|PDB:1H69}.
FT   HELIX       165    173       {ECO:0000244|PDB:1D4A}.
FT   TURN        174    177       {ECO:0000244|PDB:1D4A}.
FT   HELIX       178    180       {ECO:0000244|PDB:1D4A}.
FT   STRAND      188    190       {ECO:0000244|PDB:1D4A}.
FT   HELIX       193    195       {ECO:0000244|PDB:1D4A}.
FT   HELIX       198    212       {ECO:0000244|PDB:1D4A}.
FT   HELIX       213    217       {ECO:0000244|PDB:1D4A}.
FT   HELIX       226    228       {ECO:0000244|PDB:1D4A}.
FT   HELIX       233    235       {ECO:0000244|PDB:1D4A}.
FT   STRAND      237    239       {ECO:0000244|PDB:1H69}.
FT   HELIX       241    248       {ECO:0000244|PDB:1D4A}.
FT   STRAND      254    256       {ECO:0000244|PDB:1D4A}.
FT   TURN        266    270       {ECO:0000244|PDB:1D4A}.
SQ   SEQUENCE   274 AA;  30868 MW;  A4010462AD00F3FE CRC64;
     MVGRRALIVL AHSERTSFNY AMKEAAAAAL KKKGWEVVES DLYAMNFNPI ISRKDITGKL
     KDPANFQYPA ESVLAYKEGH LSPDIVAEQK KLEAADLVIF QFPLQWFGVP AILKGWFERV
     FIGEFAYTYA AMYDKGPFRS KKAVLSITTG GSGSMYSLQG IHGDMNVILW PIQSGILHFC
     GFQVLEPQLT YSIGHTPADA RIQILEGWKK RLENIWDETP LYFAPSSLFD LNFQAGFLMK
     KEVQDEEKNK KFGLSVGHHL GKSIPTDNQI KARK
//
